As of Feb 10
| -0.09 / -3.61%|
The 2 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a +87.50% increase from the last price of 2.40.
The current consensus among 3 polled investment analysts is to Hold stock in Accretive Health Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.